Harveshp Mogal1, Sarah A Vermilion1, Rebecca Dodson1, Fang-Chi Hsu2, Russell Howerton1, Perry Shen1, Clancy J Clark3,4. 1. Division of Surgical Oncology, Department of General Surgery, Wake Forest University Baptist Medical Center, Winston-Salem, NC, USA. 2. Department of Biostatistical Sciences, Wake Forest University Baptist Medical Center, Winston-Salem, NC, USA. 3. Division of Surgical Oncology, Department of General Surgery, Wake Forest University Baptist Medical Center, Winston-Salem, NC, USA. cjclark@wakehealth.edu. 4. Division of Surgical Oncology, Department of Surgery, Medical Center Boulevard, Winston-Salem, NC, USA. cjclark@wakehealth.edu.
Abstract
BACKGROUND: Pancreatic cancer is a disease of older adults, who may present with limited physiologic reserve. The authors hypothesized that a frailty index can predict postoperative outcomes after pancreaticoduodenectomy (PD). METHODS: All patients who underwent PD were identified in the 2005-2012 NSQIP Participant Use File. Patients undergoing emergency procedures, those with an American Society of Anesthesiologists (ASA) classification of five, and those with a diagnosis of preoperative sepsis were excluded from the study. A modified frailty index (mFI) was defined by 11 variables within the National Surgical Quality Improvement Program (NSQIP) previously used for the Canadian Study of Health and Aging-Frailty Index. An mFI score of 0.27 or higher was defined as a high mFI. Uni- and multivariate analyses were performed to evaluate postoperative outcomes. RESULTS: This study enrolled 9986 patients (age 65 ± 12 years, 48.8% female) who underwent PD. Of these patients, 6.4% (n = 637) had a high mFI (>0.27). Increasing mFI was associated with higher prevalence of postoperative morbidity (p < 0.001) and 30-days mortality (p < 0.001). In the univariate analysis, high mFI was associated with increased morbidity (odds ratio [OR] 1.68; 95% confidence interval [CI] 1.43-1.97; p < 0.001) and 30-days mortality (OR 2.45; 95% CI 1.74-3.45; p < 0.001). After adjustment for age, sex, ASA classification, albumin level, and body mass index (BMI), high mFI remained an independent preoperative predictor of postoperative morbidity (OR 1.544; 95% CI 1.289-1.850; p < 0.0001) and 30-days mortality (OR 1.536; 95% CI 1.049-2.248; p = 0.027). CONCLUSIONS: High mFI is associated with postoperative morbidity and mortality after PD and can aid in preoperative risk stratification.
BACKGROUND:Pancreatic cancer is a disease of older adults, who may present with limited physiologic reserve. The authors hypothesized that a frailty index can predict postoperative outcomes after pancreaticoduodenectomy (PD). METHODS: All patients who underwent PD were identified in the 2005-2012 NSQIP Participant Use File. Patients undergoing emergency procedures, those with an American Society of Anesthesiologists (ASA) classification of five, and those with a diagnosis of preoperative sepsis were excluded from the study. A modified frailty index (mFI) was defined by 11 variables within the National Surgical Quality Improvement Program (NSQIP) previously used for the Canadian Study of Health and Aging-Frailty Index. An mFI score of 0.27 or higher was defined as a high mFI. Uni- and multivariate analyses were performed to evaluate postoperative outcomes. RESULTS: This study enrolled 9986 patients (age 65 ± 12 years, 48.8% female) who underwent PD. Of these patients, 6.4% (n = 637) had a high mFI (>0.27). Increasing mFI was associated with higher prevalence of postoperative morbidity (p < 0.001) and 30-days mortality (p < 0.001). In the univariate analysis, high mFI was associated with increased morbidity (odds ratio [OR] 1.68; 95% confidence interval [CI] 1.43-1.97; p < 0.001) and 30-days mortality (OR 2.45; 95% CI 1.74-3.45; p < 0.001). After adjustment for age, sex, ASA classification, albumin level, and body mass index (BMI), high mFI remained an independent preoperative predictor of postoperative morbidity (OR 1.544; 95% CI 1.289-1.850; p < 0.0001) and 30-days mortality (OR 1.536; 95% CI 1.049-2.248; p = 0.027). CONCLUSIONS: High mFI is associated with postoperative morbidity and mortality after PD and can aid in preoperative risk stratification.
Authors: F Ghignone; B L van Leeuwen; I Montroni; M G Huisman; P Somasundar; K L Cheung; R A Audisio; G Ugolini Journal: Eur J Surg Oncol Date: 2015-12-17 Impact factor: 4.424
Authors: Meera R Chappidi; Max Kates; Hiten D Patel; Jeffrey J Tosoian; Deborah R Kaye; Nikolai A Sopko; Danny Lascano; Jen-Jane Liu; James McKiernan; Trinity J Bivalacqua Journal: Urol Oncol Date: 2016-02-15 Impact factor: 3.498
Authors: Keith J Roberts; Rowland Storey; James Hodson; Andrew M Smith; Gareth Morris-Stiff Journal: Pancreatology Date: 2013-05-07 Impact factor: 3.996
Authors: Keith J Roberts; James Hodson; Homoyoon Mehrzad; Ravi Marudanayagam; Robert P Sutcliffe; Paolo Muiesan; John Isaac; Simon R Bramhall; Darius F Mirza Journal: HPB (Oxford) Date: 2013-11-08 Impact factor: 3.647
Authors: A C Panayi; A R Orkaby; D Sakthivel; Y Endo; D Varon; D Roh; D P Orgill; R L Neppl; H Javedan; S Bhasin; I Sinha Journal: Am J Surg Date: 2018-11-27 Impact factor: 2.565
Authors: Heidi Lindroth; Lisa Bratzke; Sara Twadell; Paul Rowley; Janie Kildow; Mara Danner; Lily Turner; Brandon Hernandez; Roger Brown; Robert D Sanders Journal: Int J Geriatr Psychiatry Date: 2019-04-23 Impact factor: 3.485
Authors: X Serra-Aracil; S Serra-Pla; L Mora-Lopez; A Pallisera-Lloveras; M Labro-Ciurans; S Navarro-Soto Journal: Surg Endosc Date: 2018-06-22 Impact factor: 4.584
Authors: Andrew A Gumbs; Elie Chouillard; Mohamed Abu Hilal; Roland Croner; Brice Gayet; Michel Gagner Journal: Surg Endosc Date: 2020-11-04 Impact factor: 4.584